• FOLLOW US
Video Player
  • Email
  • share

Jim Cramer is Neutral on Mannkind's Afrezza Inhaled Insulin

TheStreet's Jim Cramer says many people felt Mannkind's inhaled insulin drug Afrezza would fail and as a result, 28-percent of the float was short and any good news would get the stock going. On the other hand, those who believe in the drug say this

http://www.wusa9.com/video/3422788284001/1/Jim-Cramer-is-Neutral-on-Mannkinds-Afrezza-Inhaled-Insulin http://cdn.newslook.com/14/14e352b4c0eeaa2ae36f65ed36f13a12/images/frame_ext.jpg Jim Cramer is Neutral on Mannkind's Afrezza Inhaled Insulin TheStreet's Jim Cramer says many people felt Mannkind's inhaled insulin drug Afrezza would fail and as a result, 28-percent of the float was short and any good news would get the stock going. On the other hand, those who believe in the drug say this jim cramerFinanceyoutubeYahoo!newslook 00:42

Next Up

    

More Videos